Results 141 to 150 of about 63,834 (200)

HIV Reverse Transcriptase and Protease Genes Variability Can Be a Biomarker Associated with HIV and Hepatitis B or C Coinfection. [PDF]

open access: yesSci Rep, 2018
Cantão NM   +9 more
europepmc   +1 more source

Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptase

open access: green, 1995
Sjoerd H. van der Burg   +5 more
openalex   +2 more sources

Pharmacophore-based design of novel 3-hydroxypyrimidine-2,4-dione subtypes as inhibitors of HIV reverse transcriptase-associated RNase H: Tolerance of a nonflexible linker. [PDF]

open access: yesEur J Med Chem, 2019
Tang J   +9 more
europepmc   +1 more source

HIV-1 Drug Susceptibilities and Reverse Transcriptase Mutations in Patients Receiving Combination Therapy with Didanosine and Delavirdine

open access: bronze, 1997
Lisa M. Demeter   +8 more
openalex   +1 more source

Reduced Susceptibility of Human Immunodeficiency Virus Type 1 (HIV-1) from Patients with Primary HIV Infection to Nonnucleoside Reverse Transcriptase Inhibitors Is Associated with Variation at Novel Amino Acid Sites [PDF]

open access: green, 2000
Andrew Brown   +13 more
openalex   +1 more source

Synthetic α-Hydroxytropolones as Inhibitors of HIV Reverse Transcriptase Ribonuclease H Activity. [PDF]

open access: yesMedchemcomm, 2016
Murelli RP   +10 more
europepmc   +1 more source

6-Biphenylmethyl-3-hydroxypyrimidine-2,4-diones potently and selectively inhibited HIV reverse transcriptase-associated RNase H. [PDF]

open access: yesEur J Med Chem, 2018
Wang L   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy